C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Makes New Investment in The Cooper Companies, Inc. (NASDAQ:COO)

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 6,970 shares of the medical device company’s stock, valued at approximately $691,000.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Ashton Thomas Securities LLC bought a new position in shares of Cooper Companies in the 3rd quarter worth $25,000. Byrne Asset Management LLC purchased a new stake in Cooper Companies in the 4th quarter valued at about $33,000. Covestor Ltd increased its position in shares of Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. raised its stake in shares of Cooper Companies by 191.0% during the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after purchasing an additional 275 shares during the period. Finally, West Financial Advisors LLC purchased a new position in Cooper Companies in the fourth quarter valued at about $49,000. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

NASDAQ:COO opened at $93.68 on Friday. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The firm has a market cap of $18.70 billion, a price-to-earnings ratio of 48.04, a price-to-earnings-growth ratio of 2.41 and a beta of 1.00. The company has a 50 day moving average price of $94.15 and a 200-day moving average price of $99.76.

Cooper Companies (NASDAQ:COO) last issued its earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. During the same period in the prior year, the business earned $0.87 earnings per share. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analysts Forecast Growth

COO has been the subject of several recent research reports. StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Citigroup decreased their price target on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Morgan Stanley reduced their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Finally, Wells Fargo & Company boosted their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and a consensus price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.